October 24, 2023 10:51 AM EDT
News Briefing

Brain­Storm to lay off work­ers; Lil­ly inks a sub­cu­ta­neous deal

Max Gelman

Senior Editor

Jaimy Lee

Deputy Editor

Plus, news about Mod­er­na, Caris Life Sci­ences and Ther­at­e­ch­nolo­gies:

Brain­Storm’s lay­offs: Brain­Storm Cell Ther­a­peu­tics said Tues­day it’s let­ting go of 30 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times